TI
ADVM

Turner Investments’s Adverum Biotechnologies ADVM Stock Holding History

Turner Investments’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,500
Closed -$73K – 216
2016
Q4 		$73K Buy
2,500
+2,000
+400% +$65.4K 0.03% 239
2016
Q3 		$21K Buy
+500
New +$19K 0.01% 178
2015
Q4 		– Sell
-11,109
Closed -$915K – 217
2015
Q3 		$915K Buy
+11,109
New +$1.42M 0.19% 152
2015
Q2 		– Sell
-2,982
Closed -$1.21M – 244
2015
Q1 		$1.21M Buy
+2,982
New +$1.26M 0.22% 138

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Turner Investments's ADVM Position: Q1 2017 in Review

Turner Investments sold out of Adverum Biotechnologies (ADVM) in Q1 2017, closing a stake of 2,500 shares — an estimated $73K sold.

Turner Investments first reported a position in ADVM in Q1 2015 and held it in 4 quarters. The position peaked at $1.21M in Q1 2015. 75 funds tracked by Wall St. Rank hold ADVM as of Q1 2017.

  • Turner Investments reported no remaining Adverum Biotechnologies position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 2,500 Adverum Biotechnologies shares in Q1 2017, an estimated $73K.
  • Turner Investments first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 4 quarters.
  • Turner Investments's Adverum Biotechnologies position peaked at $1.21M in Q1 2015.
  • 75 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.